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Abstract: Objectives: As the relationship between diabetes mellitus and thyroid dysfunction is well
known, it is important to investigate the factors influencing this association. Continuity of care is
associated with better quality of care and outcomes, such as reduced complications, among diabetes
patients. Therefore, the purpose of this study was to investigate the association between continuity of
care and the onset of thyroid dysfunction among diabetes patients. Methods: We used Korean National
Health Insurance Service National Sample Cohort data from 2002 to 2013. Our final study population
included 16,806 newly diagnosed diabetes patients who were older than 45 years of age. Continuity
of care was measured using the Continuity of Care index. The dependent variable was the onset
of thyroid disorder. Cox proportional hazard regression models were used for statistical analyses.
Results: Diabetes patients with low continuity of care were at increased risk of the onset of thyroid
disorder compared with those with high continuity of care (hazard ratio (HR): 1.28, 95% confidence
interval (CI): 1.07-1.54). Subgroup analyses showed that this association was significant within
patients with type 2 diabetes (HR: 1.24, 95% CI: 1.01-1.52) or whose main attending site was a local
clinic (HR: 1.32, 95% CI: 1.07-1.64). Conclusions: Our results show that diabetes patients with low
continuity of care are more likely to experience the onset of thyroid disorder. Therefore, improving
continuity of care could be a reasonable method of preventing complications or comorbidities,
including thyroid disorder, among diabetes patients.
Keywords: diabetes; continuity of care; thyroid disorder; complication; comorbidity
1. Introduction
Diabetes is a common chronic disease that cannot be easily treated and causes severe complications.
This severe non-communicable disease has been increasing in prevalence worldwide. According to the
International Diabetes Federation, three people are newly diagnosed with diabetes every 10 seconds
globally; additionally, it is predicted that 10% of people will suffer from diabetes by 2030 [1]. Diabetes is
a metabolic disorder that can cause serious secondary complications such as blindness, non-traumatic
lower extremity amputation, and terminal renal failure, resulting in massive burdens for family
members and society [2].
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Additionally, diabetes is associated with diverse comorbidities such as obesity, dyslipidemia,
and hypertension [3]. Of the various comorbidities associated with diabetes, some studies have
focused on the association between diabetes and thyroid function [4,5]. The relationship between
diabetes mellitus and thyroid dysfunction has been known for many years [5,6], and they have
shown mutual influence [7]. In addition, patients with diabetes have a higher prevalence of thyroid
diseases than the general population [8]. Diabetes seems to influence thyroid function by affecting the
conversion mechanism of T4 to T3 in the peripheral tissue, and influencing hypothalamic control of
thyroid stimulating hormone release [9,10]. As unmanaged diabetes may induce abnormal thyroid
hormone [11], continuous monitoring of diabetes patients is imperative for screening for and prevention
of thyroid disorders. In this context, continuity of care (COC) could be an important method due to its
association with positive outcomes such as preventing complications among diabetes patients [12].
COC is described as a continuous partnership between physician and patient [13] and is associated
with better quality of care [14]. COC can be achieved by knowing how a patient with a specific
past history progresses through medical care with the same physician or at the same institution [15].
Breaking of COC is known to be associated with negative outcomes. Peterson et al. suggest that
discontinuity of care, such as patient transfer to another physician, is associated with adverse events
and that communication between those physicians might decrease adverse events [16,17]. In other
words, COC has a positive effect on treatment. Previous studies report that COC has various positive
effects such as improved patients treatment adherence [14,18] and better outcomes [19]. Particularly,
COC is known to improve the quality of care of people with chronic diseases [20,21]. Among diabetes
patients, continuous care is required to control blood glucose levels and provide better quality of care,
with several previous studies suggesting that diabetes complications can be delayed or prevented by
controlling blood glucose level [22,23].
Therefore, the purpose of this study was to investigate the association between COC and the
onset of thyroid dysfunction among newly diagnosed diabetes patients. As the Korean government
encourages the use of local clinics for managing chronic diseases such as hypertension and diabetes,
we also examined whether the association between COC and the onset of thyroid disorder differs
depending on the type of diabetes and main attending site.
2. Methods
2.1. Data and Study Population
We used Korean National Health Insurance Service National Sample Cohort (NHIS-NSC) data
from 2002 to 2013. This dataset includes all medical claims from 1,025,340 individuals representing
2% of the South Korean population. For this study, we used only outpatient data from patients aged
45 years or older which were considered a risky group for diabetes [24]. We first excluded patients
who had diabetes in 2002 to 2003 to extract new onset of diabetes. We included patients who used
outpatient services for treating their diabetes mellitus more than 4 times in the first 2 years after
their diagnosis date. We excluded patients who died in the first 2 years after their diabetes diagnosis
date, who had thyroid disorder before the onset of diabetes, or who experienced the onset of thyroid
disorder within the first 2 years after their diabetes diagnosis date. Our final study population included
16,806 individuals. NHIS-NSC data is secondary data and do not contain any data which can identify
individuals. Therefore, ethical approval is exempted. The requirement for informed consent was
waived because the study was based on routinely collected administrative or claims data.
2.2. Variables
The COC index considers not only the frequency of visits to providers but also the distribution of
visits between providers [15,25]. The index ranges from 0 to 1. A score of 1 indicates that all visits are
made to the same provider, whereas a score of 0 indicates that all visits are made to different providers.
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In this study, level of COC was divided into low-group and high-group based on 0.75 as the cut-off
point [26]. COC was calculated as:
COC =
∑M
i=1 n
2
i −N
N(N − 1) (1)
where N is total number of visits, ni is number of visits to provider i, and M is the total number
of providers.
Our dependent variable was the new onset of thyroid disorder (hypothyroidism or
hyperthyroidism, ICD (International Classification of Diseases) codes ‘E03’ or ‘E05’, respectively)
during the least 2 years after the onset of diabetes.
We controlled patients’ age (45–54, 55–64, 65–74, or 75+ years), gender, income quartile (Q1 for
lowest to Q4 for highest), insurance type (National Health Insurance or Medical Aid), residential area
(metropolitan area or non-metropolitan area), type of diabetes (type 1 or 2), Charlson Comorbidity
Index, presence of disability, main attending site (general hospital, hospital, or local clinic), location of
provider (capital area, metropolitan area, or non-metropolitan area), foundation of provider (public,
corporation, or private), and diabetes onset year.
2.3. Statistical Analysis
Pearson’s Chi-squared tests were used to examine general characteristics of the study population
by testing for differences in the distribution of each variable. Cox proportional hazard regression
models were used to compute hazard ratios (HRs) for the effect of COC on the onset of thyroid disorder.
Log-rank tests were conducted after verifying that there were no violations of the proportional hazards
assumption. We also conducted subgroup analyses stratified by type of diabetes and type of main
attending site to investigate whether these factors influenced the association between COC and the
onset of thyroid dysfunction.
3. Results
Table 1 shows the general characteristics of the study population. Among 16,806 diabetes patients,
3.0% (n = 504) experienced the onset of thyroid disorder, whereas 97.0% (n = 16,302) did not. Regarding
COC, 69.7% (n = 11,717) experienced high COC, whereas 30.3% (n = 5089) experienced low COC.
Regarding type of diabetes, 13.8% (n = 2314) had type 1 diabetes, whereas 86.2% (n = 14,492) had type
2 diabetes. Regarding main attending site, 69.5% (n = 11,671) used a local clinic, 22.5% (n = 3787) used
a general hospital, and 8.0% (n = 1348) used a hospital. Mean COC was 0.829 ± 0.237 for, 0.802 ± 0.248,
and 0.830 ± 0.237 for all patients, patients in the thyroid disorder group, and patients in the no thyroid
disorder group, respectively.
Table 1. The general characteristics of the study population.
Variables
Total
The Onset of Thyroid Disorder
p-ValueNo Yes
N (%) N (%) N (%)
Continuity of care index
0.0017High (≥0.75) 11,717 69.7 11,398 97.3 319 2.7
Low (<0.75) 5089 30.3 4904 96.4 185 3.6
Age group
0.0066
45~54 5748 34.2 5567 96.9 181 3.2
55~64 5501 32.7 5315 96.6 186 3.4
65~74 4024 23.9 3914 97.3 110 2.7
75+ 1533 9.1 1506 98.2 27 1.8
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Table 1. Cont.
Variables
Total
The Onset of Thyroid Disorder
p-ValueNo Yes
N (%) N (%) N (%)
Gender
<0.0001Male 9282 55.2 9095 98.0 187 2.0
Female 7524 44.8 7207 95.8 317 4.2
Income
Low 3445 20.5 3372 97.9 73 2.1
Middle 8738 52.0 8478 97.0 260 3.0
High 4623 27.5 4452 96.3 171 3.7
Insurance type
0.1183National Health
Insurance 15,895 94.6 15,410 97.0 485 3.1
Medical aids 911 5.4 892 97.9 19 2.1
Residential area
0.0716
Capital area 6926 41.2 6697 96.7 229 3.3
Metropolitan area 4272 25.4 4143 97.0 129 3.0
Rural area 5608 33.4 5462 97.4 146 2.6
Type of Diabetes Mellitus
0.0641Type 1 2314 13.8 2230 96.4 84 3.6
Type 2 14,492 86.2 14,072 97.1 420 2.9
Charlson comorbidity
index
2+ 14,803 88.1 14,328 96.8 475 3.2
1 1571 9.4 1547 98.5 24 1.5
0 432 2.6 427 98.8 5 1.2
Disability
0.1745No 14,977 89.1 14,51 96.9 459 3.1
Yes 1829 10.9 1784 97.5 45 2.5
Main attending clinic
0.6649
General hospital 3787 22.5 3672 97.0 115 3.0
Hospital 1348 8.0 1313 97.4 35 2.6
Clinic 11,671 69.5 11,317 97.0 354 3.0
Location of the main
attending clinic
0.2921Capital area 6865 40.9 6646 96.8 219 3.2
Metropolitan area 4483 26.7 4346 96.9 137 3.1
Rural area 5458 32.5 5310 97.3 148 2.7
Foundation of the main
attending clinic
0.7098Public 1606 9.6 1561 97.2 45 2.8
Corporation 3870 23.0 3747 96.8 123 3.2
Private 11,330 67.4 10,994 97.0 336 3.0
Diabetes onset year
<0.0001
2004 2466 14.7 2324 94.2 142 5.8
2005 2309 13.7 2195 95.1 114 4.9
2006 1832 10.9 1773 96.8 59 3.2
2007 1980 11.8 1915 96.7 65 3.3
2008 1983 11.8 1930 97.3 53 2.7
2009 2085 12.4 2045 98.1 40 1.9
2010 1866 11.1 1849 99.1 17 0.9
2011 2285 13.6 2271 99.4 14 0.6
Total 16,806 100.0 16,302 97.0 504 3.0
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Table 2 shows factors associated with the onset of thyroid disorder among diabetes patients.
Patients with low COC were at increased risk of the onset of thyroid disorder compared with those
with high COC (HR: 1.28, 95% confidence interval (CI): 1.07–1.54). Also, the risk of onset of thyroid
disorder decreased with increasing age. Patients aged 75+ years showed the lowest rate of onset of
thyroid disorder compared with patients aged 45–54 years (HR: 0.45, 95% CI: 0.30–0.68). Furthermore,
women had a higher risk of onset of thyroid disorder than men (HR: 2.31, 95% CI: 1.87–2.85).
Table 2. The factors associated with the onset of thyroid disorder among diabetes mellitus patients by
cox proportional hazard regression.
Variables
The Onset of Thyroid Disorder
HR 95% CI p-Value
Continuity of care (COC) index
High (≥0.75) 1.00 -
Low (<0.75) 1.28 (1.07–1.54) 0.0078
Age group
45~54 1.00 -
55~64 0.94 (0.76–1.15) 0.5247
65~74 0.66 (0.52–0.85) 0.0012
75+ 0.45 (0.30–0.68) 0.0001
Gender
Male 1.00 -
Female 2.31 (1.87–2.85) <0.0001
Income
Low 1.00 -
Middle 1.11 (0.87–1.43) 0.4047
High 1.42 (1.12–1.81) 0.0037
Insurance type
Supporter 1.00 -
Dependent 1.05 (0.84–1.30) 0.6854
Residential area
Capital area 1.00 -
Metropolitan area 0.76 (0.48–1.18) 0.2180
Rural area 0.66 (0.44–1.00) 0.0515
Type of diabetes mellitus
Type 1 1.00 -
Type 2 1.02 (0.80–1.29) 0.8931
Charlson comorbidity index
0 1.00 -
1 0.93 (0.72–1.20) 0.5754
2+ 1.07 (0.83–1.37) 0.6160
Disability
Yes 1.00 -
No 0.97 (0.71–1.32) 0.8416
Main attending clinic
General hospital 1.00 -
Hospital 0.99 (0.65–1.51) 0.9709
Clinic 1.24 (0.85–1.80) 0.2611
Location of the main attending clinic
Capital area 0.79 (0.52–1.21) 0.2809
Metropolitan area 0.96 (0.64–1.45) 0.8560
Rural area 1.00 -
Foundation of the main attending clinic
Public 1.00 -
Corporation 1.40 (0.90–2.16) 0.1328
Private 1.12 (0.81–1.54) 0.4924
Diabetes onset year
2004 1.00 -
2005 0.93 (0.73–1.20) 0.5860
2006 0.71 (0.52–0.96) 0.0280
2007 0.90 (0.66–1.23) 0.5155
2008 0.88 (0.63–1.23) 0.4529
2009 0.87 (0.60–1.27) 0.4802
2010 0.71 (0.42–1.20) 0.1995
2011 1.35 (0.74–2.45) 0.3237
HR: hazard ratio; CI: confidence interval.
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Table 3 shows the results of subgroup analyses stratified by type of diabetes and main attending
site. Regarding type of diabetes, a significant association between COC and onset of thyroid disorder
was found among patients with type 2 diabetes (HR: 1.24, 95% CI: 1.01–1.52) but not among patients
with type 1 diabetes. Regarding main attending site, a significant association between COC and onset
of thyroid disorder was found only for local clinics (HR: 1.32, 95% CI: 1.07–1.64) but not for general
hospitals or hospitals.
Table 3. The results of subgroup analyses of the association between the continuity of care and the
onset of thyroid disorder stratified by the type of diabetes mellitus and main attending clinic.
Variables
The Onset of Thyroid Disorder
High COC Low COC
HR HR 95% CI p-Value
Type of diabetes mellitus *
Type 1 1.00 1.46 (0.95–2.24) 0.0864
Type 2 1.00 1.24 (1.01–1.52) 0.0382
Main attending clinic **
General hospital 1.00 1.13 (0.75–1.68) 0.5641
Hospital 1.00 1.46 (0.73–2.90) 0.2817
Clinic 1.00 1.32 (1.07–1.64) 0.0107
* Adjusted for age, gender, income, insurance type, residential area, Charlson Comorbidity Index, disability existence,
main attending clinic, location of the main attending clinic, and foundation of the main attending clinic, diabetes
onset year. ** Adjusted for age, gender, income, insurance type, residential area, Charlson Comorbidity Index,
disability existence, type of diabetes mellitus, location of the main attending clinic, and foundation of the main
attending clinic, diabetes onset year.
4. Discussion
In this study, we investigated the association between COC and the onset of thyroid disorders
among diabetes mellitus patients in Korea. We found that individuals with low COC showed a higher
risk of thyroid disorder onset compared with those with high COC. This association was found among
patients with type 2 diabetes or who visited a local clinic as their main attending site.
Insufficient glucose control causes several complications or comorbidities among patients with
diabetes, and continuous control of blood glucose is imperative for preventing or delaying diabetes
complications or comorbidities [23]. Previous studies showed that uncontrolled glucose also affects
thyroid hormones [27,28]. Therefore, appropriate glucose control of diabetes patients should be
achieved for preventing onset of thyroid disorder among patients with diabetes. In this process,
continuity of care could have a positive effect on continuous blood glucose control.
Generally, COC has been recognized for having various positive effects on care processes, such as
enhanced communication between physician and chronic disease patients [29] and improved likelihood
of keeping follow-up appointments [30]. Additionally, provider continuity has positive effects on
the quality of care and produces better outcomes due to the formation of long-term relationships
and accumulation of knowledge between patients and providers [31]. Thus, patients with high COC
tend to have better glycemic control and more well-managed diabetes [32]. Several studies show that
diabetes patients with high COC have a lower risk of onset of complications [33,34]. Even though one
previous study showed that patients with high COC did not show statistically significant association
with thyroid outpatients visit, the study confirmed high COC was associated with reduced diabetes
ketoacidosis [35]. In addition, Knight et al. [36] showed that patients with diabetes showed lower rate
of hospitalization due to chronic diseases including thyroid disorders when their continuity of care
was high. Therefore, high COC may be related to well-controlled glycemic status, which could help
prevent the onset of thyroid disorders.
Our subgroup analyses showed statistically significant associations between COC and the onset
of thyroid disorder among type 2 diabetes. Several previous studies reported the relationship between
type 2 diabetes and thyroid disorders [37–39]. Considering this association, continuity of care could
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be one of the methods for preventing the onset of thyroid disorder among patients with diabetes.
We also found that diabetes patients whose main attending site was a local clinic showed a statistically
significant association between COC and the onset of thyroid disorder, whereas those whose main
attending site was a hospital or general hospital did not show a significant association. This finding
may be due to systematic differences among types of sites, such as physicians’ rotation systems,
consultation hours, characteristics of patients, and number of patients per physicians. Further research
is needed to determine why an association between COC and the onset of thyroid disorder was found
only for local clinics.
Our study has several limitations. First, we could not adjust other important covariates, including
educational level, working status, physical activity level or family history, which could be associated
with the onset of thyroid disorder. Second, the severity of diabetes was not included in our dataset.
Third, we defined thyroid disorder based on ICD-10 codes made when patients visited clinics and were
diagnosed with thyroid disorder; therefore, we could not detect subclinical thyroid disorder. Fourth,
we did not separate thyroid disorders into hyperthyroidism and hypothyroidism; therefore, further
study is needed to focus on each type of thyroid disorder. Fifth, the primary purpose of this data
was health insurance claims, and the accuracy of administrative data has been discussed for several
years [40]. However, a previous study which studied the accuracy of this data demonstrated a 70%
accuracy [41]. Despite these limitations, our study has the strength of using nationwide claims data
obtained from the National Health Insurance Service. Additionally, to the best of our knowledge, there
are few studies on the association between COC and the onset of thyroid disorder among diabetes
patients [35,36]. Therefore, our study could add to the body of evidence of the association.
5. Conclusions
Diabetes is a common non-communicable disease, and its management is crucial for preventing
many complications and comorbidities. Considering that diabetes and thyroid disorders are the most
prevalent endocrine diseases, our study shows that diabetes patients with low COC were more likely to
experience the onset of thyroid disorder compared to patients with high COC. High COC is associated
with better quality of care and diabetes management as well as protection from complications. Thus,
COC could be a reasonable method of preventing complications or comorbidities, including thyroid
disorder, among diabetes patients. As “medical shopping” is a healthcare problem in Korea, preventing
patients from medical shopping and enhancing their COC is needed.
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